Home › Research › Digital health tools
The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications
Schrag A, Hommel ALAJ, Lorenzl S, Meissner WG, Odin P, Coelho M, Bloem BR, Dodel R et al.. Parkinsonism & related disorders, 2020-05-21
Topic: Risk, prevention and care in population studies
Plain-language summary
Introduction There is little information on the late stages of parkinsonism. Methods We conducted a multicentre study in 692 patients with late stage parkinsonism in six European countries. Inclusion criteria were disease duration of ≥7 years and either Hoehn and Yahr stage ≥4 or Schwab and England score of 50 or less. Results Average disease duration was 15.4 (SD 7.7) years and mean total UPDRS score was 82.7 (SD 22.4). Dementia according to MDS-criteria was present in 37% of patients. Mean levodopa equivalence dose was 874.1 (SD 591.1) mg/d. Eighty two percent of patients reported falls, related to freezing (16%) or unrelated to freezing (21% of patients) or occurring both related and unrelated to freezing (45%), and were frequent in 26%. Moderate-severe difficulties were reported for turning in bed by 51%, speech by 43%, swallowing by 16% and tremor by 11%. Off-periods occurred in 68% and were present at least 50% of the day in 13%, with morning dystonia occurring in 35%. Dyskinesias were reported by 45% but were moderate or severe only in 7%. Moderate-severe fatigue, constipation, urinary symptoms and nocturia, concentration and memory problems were encountered by more than half of participants. Hallucinations (44%) or delusions (25%) were present in 63% and were moderate-severe in 15%. The association with overall disability was strongest for severity of falls/postural instability, bradykinesia, cognitive score and speech impairment. Conclusion These data suggest that current treatment of late stage parkinsonism in the community remains insufficiently effective to alleviate disabling symptoms in many patients.
What this study adds
Evidence grade: Low
The record lists 692 participants. This study of late-stage parkinsonism found that dementia was present in 37% of patients and that current treatment remains insufficiently effective to alleviate disabling symptoms in many patients. It concerns Parkinson's disease management, not treating, curing, or preventing Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Schrag, A., Hommel, A. L. A. J., Lorenzl, S., Meissner, W. G., Odin, P., Coelho, M., et al. (2020). The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications. Parkinsonism & related disorders. https://doi.org/10.1016/j.parkreldis.2020.05.016
Vancouver
Schrag A, Hommel ALAJ, Lorenzl S, Meissner WG, Odin P, Coelho M, et al. The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications. Parkinsonism & related disorders. 2020. doi:10.1016/j.parkreldis.2020.05.016. PMID: 32505085.
BibTeX
@article{schrag2020-32505085,
author = {Schrag, A. and Hommel, A. L. A. J. and Lorenzl, S. and Meissner, W. G. and Odin, P. and Coelho, M. and Bloem, B. R. and Dodel, R. and others},
title = {{The late stage of Parkinson's -results of a large multinational study on motor and non-motor complications}},
journal = {Parkinsonism \& related disorders},
year = {2020},
doi = {10.1016/j.parkreldis.2020.05.016},
pmid = {32505085},
url = {https://doi.org/10.1016/j.parkreldis.2020.05.016}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results Average disease duration was 15.4 (SD 7.7) years and mean total UPDRS score was 82.7 (SD 22.4).
- The association with overall disability was strongest for severity of falls/postural instability, bradykinesia, cognitive score and speech impairment.
- Conclusion These data suggest that current treatment of late stage parkinsonism in the community remains insufficiently effective to alleviate disabling symptoms in many patients.
Why it matters
This study of late-stage parkinsonism found that dementia was present in 37% of patients and that current treatment remains insufficiently effective to alleviate disabling symptoms in many patients. It concerns Parkinson's disease management, not treating, curing, or preventing Alzheimer's disease.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Participants692
- Evidence strengthLow
How this study scored 46/100
Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Parkinsonism & related disorders) |
| Journal's citation record | 2 / 4 | Parkinsonism & Related Disorders: journal h-index 155 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 2 / 4 | 692 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 48 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 6.0 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 2 / 6 | Cited 2.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 26 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Petra Neuser: h-index 14 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Centre National de la Recherche Scientifique: institution h-index 2,511 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 17 institution(s) in 7 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 32505085) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 46 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1016/j.parkreldis.2020.05.016
- PubMed: 32505085
- Original source →
- Free full text: Parkinsonism & Related Disorders →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Digital health tools from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.